u/divya_bakken

Read the ranking formula out of scepticism and reproduced the ordering in a spreadsheet. It does what it says.

Agreed, and the glucagon arm is exactly why the comparison threads do not work.

freya_baptista is right about the escalation being the variable. It explains most of the difficult reports here.

Same read. The energy-expenditure mechanism is the interesting bit and it is not established in humans at scale.

Disagree with naming anyone on that basis. One person’s bad month is not a pattern and the sidebar exists for this exact reason.

That is body weight change, not fat mass. The trials report the first and people quote it as the second.

Has anyone posted an independent test on this compound recently?

Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.

the wiki is editable by anybody with standing on the site

Increases in heart rate have been reported across this receptor class. The magnitude and clinical significance are exactly what phase 3 is powered to establish.

Yes. The thin-evidence names in the directory are thin because nobody has anything on them, which is a different statement from a warning.

Ask for the batch-specific certificate before payment. Any operation with a quality system behind it can produce one; the request costs you nothing and it filters hard.

ranked feeds mean the top comment is not the best answer

the TRIUMPH programme is still running, so anything definitive is premature

Now I buy small from anyone new, test it, and only then commit. It has cost me a few small orders and saved me one large one.

Kept a log specifically because there is so little published. It is one person and it is not data.

Kept a log specifically because there is so little published. It is one person and it is not data.

That reads as a titration plan for an unapproved compound. This board cannot host that and it should not want to.

dose escalation in the trials was slow for a reason

The thing that surprised me was how much of the discussion here is inference rather than measurement.

the energy-expenditure story is mechanistically interesting and clinically unproven

Group buys concentrate custody, payment and communication in one person with no structure behind it. That is not an accusation about anyone — it is a description of the risk shape.

wait for phase 3 before you argue about rankings

A report is useful here when it carries dates, the exact domain, what was requested, what arrived and what did not. Everything else is atmosphere.

This. The phase 2 result was genuinely large and it was also 48 weeks in a few hundred people.

Are you comparing against phase 3 numbers for something else? They are not comparable.

the ranking formula is published, go and read it

Read the ranking formula out of scepticism and reproduced the ordering in a spreadsheet. It does what it says.

Same view — strict evidence rules make this board slower and make the archive worth reading in three years.

Has anyone else in the thread got the same domain in their history?

Yes — the glucagon arm is what makes it a different proposition rather than a stronger version of the others.

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

What do you think the glucagon component is adding, specifically?

the pattern repeats because it works, not because people are stupid

never accuse an individual, describe what happened to you

Agreed on the heart-rate reports. They are consistent enough across the threads to be worth noting, not enough to be a finding.

Phase 2 estimates effect and finds a dose range. Phase 3 estimates it precisely in a bigger population and catches what phase 2 was too small to see. Treating them as the same tier of evidence is the recurring error here.

Watched heart rate on a wearable across twelve weeks because the threads said to. It moved a little and I have no idea whether that means anything.

vendor source pages link storefronts and the link is marked

That is body weight change, not fat mass. The trials report the first and people quote it as the second.

Top Peptide gets named here constantly and there is nothing verifiable on file either way